Zobrazeno 1 - 10
of 198
pro vyhledávání: '"Sprabery AT"'
Autor:
Anibal, James, Huth, Hannah, Li, Ming, Hazen, Lindsey, Daoud, Veronica, Ebedes, Dominique, Lam, Yen Minh, Nguyen, Hang, Hong, Phuc, Kleinman, Michael, Ost, Shelley, Jackson, Christopher, Sprabery, Laura, Elangovan, Cheran, Krishnaiah, Balaji, Akst, Lee, Lina, Ioan, Elyazar, Iqbal, Ekwati, Lenny, Jansen, Stefan, Nduwayezu, Richard, Garcia, Charisse, Plum, Jeffrey, Brenner, Jacqueline, Song, Miranda, Ricotta, Emily, Clifton, David, Thwaites, C. Louise, Bensoussan, Yael, Wood, Bradford
Artificial intelligence (AI) models trained on audio data may have the potential to rapidly perform clinical tasks, enhancing medical decision-making and potentially improving outcomes through early detection. Existing technologies depend on limited
Externí odkaz:
http://arxiv.org/abs/2404.01620
Autor:
Sprabery, Read, Evchenko, Konstantin, Raj, Abhilash, Bobba, Rakesh B., Mohan, Sibin, Campbell, Roy H.
While there exist many isolation mechanisms that are available to cloud service providers, including virtual machines, containers, etc., the problem of side-channel increases in importance as a remaining security vulnerability, particularly in the pr
Externí odkaz:
http://arxiv.org/abs/1708.09538
Autor:
Mwangi J. Murage, Nicole Princic, Julie Park, William Malatestinic, Baojin Zhu, Bilal Atiya, Scott A. Kern, Keri B. Stenger, Aubrey Trevelin Sprabery, Alexis Ogdie
Publikováno v:
ACR Open Rheumatology, Vol 3, Iss 12, Pp 879-887 (2021)
Objective To describe adherence, persistence, discontinuation, restarting, switching, dosing, and health care costs among patients with psoriatic arthritis (PsA) treated with ixekizumab (IXE). Methods MarketScan administrative claims databases were u
Externí odkaz:
https://doaj.org/article/aa2fd13e79474ac9b1c0b9d8c8cc1039
Autor:
Bernard Combe, Tsen-Fang Tsai, J. Eugene Huffstutter, Aubrey Trevelin Sprabery, Chen-Yen Lin, So Young Park, Andris Kronbergs, Matthew M. Hufford, Peter Nash
Publikováno v:
Arthritis Research & Therapy, Vol 23, Iss 1, Pp 1-10 (2021)
Abstract Background The efficacy and safety of ixekizumab (IXE) with and without continuous concomitant methotrexate (MTX), for up to 52 weeks of treatment, were evaluated in patients with active psoriatic arthritis (PsA). Methods Patients with activ
Externí odkaz:
https://doaj.org/article/b16932c648be4716aed14c4aba8b6e9a
Autor:
Ana-Maria Orbai, Julie A. Birt, Elizabeth A. Holdsworth, Nicola Booth, William N. Malatestinic, Aubrey T. Sprabery, Anthony M. Reginato
Publikováno v:
Rheumatology and Therapy, Vol 7, Iss 4, Pp 937-948 (2020)
Abstract Introduction Enthesitis is a core outcome domain assessed in psoriatic arthritis (PsA) clinical trials. Limited evidence describes the impact of enthesitis on patient-reported outcomes (PROs) and physician satisfaction with current treatment
Externí odkaz:
https://doaj.org/article/c167ec2cfc9247df933f486e289aa221
Publikováno v:
Rheumatology and Therapy, Vol 6, Iss 3, Pp 379-391 (2019)
Abstract Introduction The Work Productivity and Activity Impairment Specific Health Problem Questionnaire (WPAI:SHP) is used to assess the impact of an intervention on work productivity in patients with psoriatic arthritis (PsA). Unfortunately, studi
Externí odkaz:
https://doaj.org/article/145001731ab64e9e8275516c4c068898
Autor:
Atul A Deodhar, Bernard Combe, Ana P Accioly, Rebecca Bolce, Danting Zhu, Amanda M Gellett, Aubrey Trevelin Sprabery, Gerd-Rüdiger R Burmester
Publikováno v:
Annals of the Rheumatic Diseases. 81:944-950
ObjectivesIxekizumab, a high-affinity monoclonal antibody that selectively targets interleukin 17A (IL-17A), has shown significant efficacy in the treatment of psoriatic arthritis (PsA) and sustained long-term clinical response without unexpected new
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::93a118c8e6f744ca9c71ac68fe1975b8
https://doi.org/10.1136/annrheumdis-2021-222027
https://doi.org/10.1136/annrheumdis-2021-222027
Publikováno v:
Journal of Pharmacy Practice. 35:606-611
Objective: To evaluate the effect of a medication assistance program and the addition of pharmacist management on clinical outcomes in patients with hypertension and diabetes through an Advanced Pharmaceutical Care program. Methods: This was a prospe
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::b43c98e5b41d74c927f93420b491eb63
https://doi.org/10.1177/08971900211002138
https://doi.org/10.1177/08971900211002138
Autor:
Chen-Yen Lin, Anthony Turkiewicz, Amanda M. Gellett, Carlos Sesin, Bruce Kirkham, Aubrey Trevelin Sprabery
Publikováno v:
Rheumatology (Oxford, England)
Objective To evaluate the efficacy of ixekizumab (IXE), a monoclonal antibody selectively targeting interleukin-17A, in patients with inadequate response to one or two TNF inhibitors (TNFi). Methods A phase 3 study (SPIRIT-P2; NCT02349295) randomized
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::6449055df49fb7b75e9f3abc8336357f
https://doi.org/10.1093/rheumatology/keaa824
https://doi.org/10.1093/rheumatology/keaa824
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.